Applicant, as named in the Orange Book

Twi Pharms

Next listed expiry: Forfivo Xl on 23 Aug 2028. 1 products with live protection, 3 without.

Products with listed protection

Drug	Ingredient	Earliest generic entry	Basis
Forfivo Xl NDA 022497 bupropion hydrochloride	bupropion hydrochloride	23 Aug 2028 patent	patent

Recent events

Forfivo Xl · Generic approved · ANDA 217898, Annora PharmaApproved 1 Oct 2025Detected 25 Oct 2026
Forfivo Xl · Generic approved · ANDA 220529, Yichang HumanwellApproved 4 May 2026Detected 25 Oct 2026
Forfivo Xl · Generic approved · ANDA 216051, Aurobindo Pharma LtdApproved 21 Jul 2026Detected 25 Oct 2026
Forfivo Xl · Generic approved · ANDA 218567, Macleods PharmsApproved 23 Jun 2026Detected 25 Oct 2026

Products without listed protection (3)

Drug	Ingredient	Earliest generic entry	Basis
Naprelan NDA 020353 · 3 strengths naproxen sodium	naproxen sodium	open now no listed protection	no listed protection
Tenormin NDA 018240 · 3 strengths atenolol	atenolol	open now no listed protection	no listed protection
Zestril NDA 019777 · 6 strengths lisinopril	lisinopril	open now no listed protection	no listed protection